Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1483 of 5804
-
New study aims to predict sudden death in severe epilepsy
Knowledge-focused OngoingDravet Syndrome (DS) is a severe epileptic encephalopathy, which main cause is mutations of SCN1A, the gene coding for the Nav1.1 voltage-gated sodium channel. DS is characterized by childhood onset, severe cognitive deficit and drug-resistant seizures, including several generali…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Can a video game teach job skills to people with autism?
Disease control CompletedNearly 50,000 youth with autism spectrum disorder (ASD) transition from high school to adult life each year with only 25% of these transition-age youth with ASD (TAY-ASD) getting jobs within 2 years of graduation. TAY-ASD's ability to sustain employment is even more challenging d…
Phase: NA • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Digital dream team: personalized advice may cut Long-Term sick leave
Disease control OngoingLong-term sick leave is a challenge in Norway, and the healthcare and labor- and welfare services are often not coordinated in helping the sick-listed employees return to work. In this study, the investigators want to evaluate the effectiveness of an intervention where an expert …
Phase: NA • Sponsor: St. Olavs Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New combo therapy offers hope for rare skin cancer patients
Disease control Recruiting nowTo learn if a form of radiation therapy (called ultra-low-dose - total skin electron beam therapy \[ULD-TSEBT\]) in combination with brentuximab vedotin can help to control mycosis fungoides
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug cocktail aims to make inoperable abdominal cancers operable
Disease control CompletedBackground: Tumors that have spread to the lining of the abdomen from other cancers, such as cancer of the appendix, colon, or ovary, are called peritoneal carcinomatosis. In most cases, outcomes are poor. Researchers want to test a new treatment. Objective: To learn if the co…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a bone drug halt skeletal damage in kids with rare disease?
Disease control CompletedBackground: Fibrous dysplasia (FD) is a disease that affects the bones. It causes bone lesions that can become weak and lead to fractures, deformity, and nerve injuries. FD bone lesions begin to develop soon after birth and grow during childhood. The lesions stop growing in adul…
Phase: PHASE2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Your own tumor cells could be the key to fighting cancer
Disease control Completed20-60 participants are expected to be enrolled for the Phase I clinical trial which is further divided into two parts: a "3+3" dose escalation study and an expanded enrollment study. The Phase I clinical trial is expected to be finished in 36 months. To be specific, the dose esc…
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Brain training for anxious kids: a 45-minute computer session may alter error responses
Knowledge-focused CompletedAnxiety disorders are the most common form of psychopathology, and frequently begin in childhood, resulting in lifelong impairment. Increased brain activity after making mistakes, as reflected by the error-related negativity (ERN), is observed in people with anxiety disorders, ev…
Phase: NA • Sponsor: Florida State University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Could cannabis calm Alzheimer's agitation? new trial underway
Symptom relief Recruiting nowThe purpose of this study is to assess the efficacy of the oral medication IGC-AD1, a THC-based (Delta-9-Tetrahydrocannabinol) formulation administered twice a day on Agitation in patients with mild to severe dementia from Alzheimer's.
Phase: PHASE2 • Sponsor: IGC Pharma, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New pill could tame fibroid symptoms without surgery
Symptom relief CompletedMulti-center, randomized, double-blind, parallel-group study to confirm superiority of KLH-2109 to placebo in uterine fibroids patient with menorrhagia and pain
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Olive oil and betaine gel may ease radiation mouth pain
Symptom relief Recruiting nowThe use of a novel topical mucosa composition (XCM-OM118) comprising 2-(trimethylazaniumyl) acetate; (2R,3R,4S)-pentane-1,2,3,4,5-pentol; Hexadecanoic acid; (9Z, 12Z)-octadeca-9,12-dienoic acid; octadecanoic acid; (Z)-hexadec-9-enoic acid; (Z)-octadec-9-enoic acid) delivered as a…
Phase: NA • Sponsor: Mucosa Innovations, S.L. • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New antibody combo aims to boost immune attack on Hard-to-Treat cancers
Disease control OngoingResearchers are looking for a better way to treat people who have advanced solid tumors. Advanced solid tumors are solid cancers that may have spread to nearby tissue, lymph nodes and/or to distant parts of the body and that are unlikely to be cured or controlled with currently a…
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug aims to tame brain swelling after bleeding stroke
Disease control OngoingThis first-in-patient phase 2a pilot study will assess the safety and tolerability of MW01-6-189WH (hereafter called MW189) in patients with Intracerebral Hemorrhage (ICH).
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Telehealth program aims to get HIV treatment to people who inject drugs faster
Disease control CompletedThe purpose of this study is to test 2 different methods for offering medications that treat HIV, cure Hepatitis C Virus (HCV) (if applicable) and treat substance use disorder (if desired) to people who inject drugs.
Phase: NA • Sponsor: University of Miami • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for kids with Crohn's: drug combo trial launches
Disease control Recruiting nowThis is a randomized controlled trial to compare the efficacy and safety of infliximab and immunosuppressives therapy alone or in combination for pediatric Crohn's disease.
Phase: PHASE4 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Zinc spray may stop painful mouth sores in cancer radiation
Prevention Recruiting nowOral Mucositis (OM) consists in the painful inflammation and ulceration of the mucous membranes lining the digestive tract, lasting between 7 and 98 days; and starts as an acute inflammation of oral mucosa, tongue, and pharynx after RT exposure. Gel X spray is a product based on…
Phase: NA • Sponsor: Catholic University of the Sacred Heart • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC
-
Can Extra-Strength statins stop heart attacks before they start?
Disease control OngoingCurrent guidelines recommend moderate-intensity lipid-lowering therapy (goal for LDL-C \<2.6 mmol/L or 30%-50% reduction from baseline) for patients with intermediate 10-year ASCVD risk. In these patients, early coronary atherosclerotic plaques detected by coronary CT angiography…
Phase: NA • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Tiny Drug-Carrying particles aim to blast bladder cancer cells
Disease control Recruiting nowThis clinical trial is to determine the safety and effectiveness of an investigational bladder cancer drug named "PLZ4-coated paclitaxel-loaded nanoscale micelle (PPM)." PPM is tiny particles that contain the chemotherapy drug paclitaxel. PLZ4 is a molecule that can possibly guid…
Phase: PHASE1 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 26, 2026 13:05 UTC
-
Could a malaria drug help fight resistant colon cancer?
Disease control TerminatedThis is a Phase II, open label, single-arm trial study of adding hydroxychloroquine to encorafenib and cetuximab in patients with metastatic BRAF V600E colon cancer with progression on at least 1 prior line of therapy. We hypothesize that autophagy is a major mechanism of resista…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New shot shows promise for tough eczema in early trial
Disease control CompletedThis trial was designed to evaluate the efficacy and safety of SHR-1819 injection in patients with atopic dermatitis.
Phase: PHASE2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC